Ramsingh, G <br/><br/>
A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML.  [electronic resource] 

 -  Leukemia  Mar 2013 
 - 725-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Letter 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2012.214  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Azacitidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Lenalidomide<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prognosis<br/>Prospective Studies<br/>Remission Induction<br/>Thalidomide--administration & dosage<br/>Young Adult